Literature DB >> 23612258

Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene.

Fatih Ezgu1, Pavel Krejci, Wiliam R Wilcox.   

Abstract

Mutations in the FH gene cause the deficiency of the enzyme fumarase (fumarate hydratase, EC 4.2.1.2) which result in autosomal recessive fumaric aciduria in early childhood with failure to thrive, seizures, developmental delay, mental retardation, hypotonia and sometimes with polycythemia, leukopenia, and neutropenia. Many children with fumarate hydratase deficiency do not survive infancy or childhood; those surviving beyond childhood have severe psychomotor retardation. Recently, FH gene was also identified as a "non-classical" tumor suppressor gene and heterozygous mutations were shown to cause multiple cutaneous and uterine leiomyomas as well as hereditary leiomyomatosis and renal cell cancer. A male patient who was referred to investigate the etiology of psychomotor retardation was later diagnosed to have fumaric aciduria due to the combination of a previously known (c.1431_1433dupAAA) and a novel (c.782G>T) mutation. The patient had an unusually mild clinical course without acidotic attacks. Interestingly his father who was heterozygous for the c.1431_1433dupAAA mutation in the FH gene had cutaneous leiomyoma.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612258     DOI: 10.1016/j.gene.2013.03.026

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma.

Authors:  Liying Zhang; Michael F Walsh; Sowmya Jairam; Diana Mandelker; Yi Zhong; Yelena Kemel; Ying-Bei Chen; David Musheyev; Ahmet Zehir; Gowtham Jayakumaran; Edyta Brzostowski; Ozge Birsoy; Ciyu Yang; Yirong Li; Joshua Somar; Deborah DeLair; Nisha Pradhan; Michael F Berger; Karen Cadoo; Maria I Carlo; Mark E Robson; Zsofia K Stadler; Christine A Iacobuzio-Donahue; Vijai Joseph; Kenneth Offit
Journal:  Hum Mutat       Date:  2019-09-03       Impact factor: 4.878

Review 2.  Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.

Authors:  Tesfaye W Tefera; Kah Ni Tan; Tanya S McDonald; Karin Borges
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

3.  Fumarase Deficiency: A Safe and Potentially Disease Modifying Effect of High Fat/Low Carbohydrate Diet.

Authors:  B Ryder; F Moore; A Mitchell; S Thompson; J Christodoulou; S Balasubramaniam
Journal:  JIMD Rep       Date:  2017-10-21

4.  Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.

Authors:  Eric Lu; Kathryn E Hatchell; Sarah M Nielsen; Edward D Esplin; Karen Ouyang; Keith Nykamp; Shirin Zavoshi; Shantao Li; Liying Zhang; Blake R Wilde; Heather R Christofk; Paul C Boutros; Brian Shuch
Journal:  Cancer       Date:  2021-11-01       Impact factor: 6.921

5.  Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer.

Authors:  Tiffiney R Hartman; Elena V Demidova; Randy W Lesh; Lily Hoang; Marcy Richardson; Andrea Forman; Lisa Kessler; Virginia Speare; Erica A Golemis; Michael J Hall; Mary B Daly; Sanjeevani Arora
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.